GR1009632B - Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος - Google Patents
Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματοςInfo
- Publication number
- GR1009632B GR1009632B GR20180100307A GR20180100307A GR1009632B GR 1009632 B GR1009632 B GR 1009632B GR 20180100307 A GR20180100307 A GR 20180100307A GR 20180100307 A GR20180100307 A GR 20180100307A GR 1009632 B GR1009632 B GR 1009632B
- Authority
- GR
- Greece
- Prior art keywords
- xyloglucan
- lactoferrin
- simethicone
- proanthocyanidin
- gastrointestinal
- Prior art date
Links
- 102000010445 Lactoferrin Human genes 0.000 title abstract 3
- 108010063045 Lactoferrin Proteins 0.000 title abstract 3
- 229920002000 Xyloglucan Polymers 0.000 title abstract 3
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 title abstract 3
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title abstract 3
- 229940078795 lactoferrin Drugs 0.000 title abstract 3
- 235000021242 lactoferrin Nutrition 0.000 title abstract 3
- 229940083037 simethicone Drugs 0.000 title abstract 3
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 title abstract 2
- 229920001991 Proanthocyanidin Polymers 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 210000001635 urinary tract Anatomy 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 abstract 3
- 235000020237 cranberry extract Nutrition 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
- B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
- B65D51/2807—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
- B65D51/2814—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it
- B65D51/2828—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil
- B65D51/2835—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil ruptured by a sharp element, e.g. a cutter or a piercer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Διατροφικό συμπλήρωμα, σε μορφή πόσιμου εναιωρήματος μίας δόσης, το οποίο περιέχει ως δραστικά συστατικά λακτοφερίνη, ξυλογλυκάνη, προανθοκυανιδίνες και σιμεθικόνη, χρήσιμο για την πρόληψη των λοιμώξεων του γαστρεντερικού και του ουροποιητικού συστήματος. Τα συστατικά του διατροφικού συμπληρώματος φυλάσσονται σε μία διάταξη πώματος με αποθηκευτικό χώρο και φιαλίδιο, όπου το πώμα με τον αποθηκευτικό χώρο περιέχει μία σύνθεση σε μορφή σκόνης που βασίζεται σε λακτοφερίνη, ξυλογλυκάνη και εκχύλισμα κράνμπερι, το δε φιαλίδιο περιέχει ένα αρωματισμένο εναιώρημα σιμεθικόνης. Η στερεή κονιοποιημένη σύνθεση λακτοφερίνης, ξυλογλυκάνης και εκχυλίσματος κράμπερι που περιέχεται στο πώμα με τον αποθηκευτικό χώρο, αναμειγνύεται με το αρωματισμένο εναιώρημα σιμεθικόνης που περιέχεται στο φιαλίδιο, μέσω διαδικασίας ενός σταδίου ακριβώς πριν από τη στιγμή της χρήσης και οδηγεί σε ένα πόσιμο εύγεστο εναιώρημα που μπορεί να καταναλωθεί άμεσα από το φιαλίδιο.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20180100307A GR1009632B (el) | 2018-07-09 | 2018-07-09 | Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος |
| DK19749778.7T DK3820466T3 (da) | 2018-07-09 | 2019-07-05 | Kosttilskud, egnet til oral indgivelse, omfattende lactoferrin, xyloglucan, proanthocyanidiner og simethicon til samlet forebyggelse af mave-tarmkanal- og urinvejsinfektioner |
| PCT/GR2019/000049 WO2020012203A1 (en) | 2018-07-09 | 2019-07-05 | Nutritional supplement,suitable for oral administration,comprising lactoferrin,xyloglucan,proanthocyanidins and simethicone for the joint prevention of gastroinntestinal and urinary tract infections |
| PT197497787T PT3820466T (pt) | 2018-07-09 | 2019-07-05 | Suplemento nutricional, adequado para administração oral, compreendendo lactoferrina, xiloglucano, proantocianidinas e simeticone para a prevenção conjunta de infeções gastrintestinais e urinárias |
| ES19749778T ES2928471T3 (es) | 2018-07-09 | 2019-07-05 | Suplemento nutricional, apto para administración oral, que comprende lactoferrina, xiloglucano, proantocianidinas y simeticona para la prevención conjunta de infecciones del tracto gastrointestinal y urinario |
| EP19749778.7A EP3820466B1 (en) | 2018-07-09 | 2019-07-05 | Nutritional supplement, suitable for oral administration, comprising lactoferrin, xyloglucan, proanthocyanidins and simethicone for the joint prevention of gastrointestinal and urinary tract infections |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20180100307A GR1009632B (el) | 2018-07-09 | 2018-07-09 | Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1009632B true GR1009632B (el) | 2019-10-25 |
Family
ID=67544272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20180100307A GR1009632B (el) | 2018-07-09 | 2018-07-09 | Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3820466B1 (el) |
| DK (1) | DK3820466T3 (el) |
| ES (1) | ES2928471T3 (el) |
| GR (1) | GR1009632B (el) |
| PT (1) | PT3820466T (el) |
| WO (1) | WO2020012203A1 (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1011186B (el) * | 2025-06-10 | 2026-05-07 | Ιουλια Τσετη | Σκευασμα με σιμεθικονη, πολυαιθυλενογλυκολη και υδροξυαιθυλοκυτταρινη |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0990438A1 (en) * | 1998-09-21 | 2000-04-05 | McNEIL-PPC, INC. | Heat stable antacid and antigas suspensions |
| US20060269535A1 (en) * | 2005-05-31 | 2006-11-30 | Naidu A S | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy |
| WO2008018111A2 (en) * | 2006-08-09 | 2008-02-14 | Opocrin S.P.A. | Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections |
| WO2015158771A1 (en) * | 2014-04-15 | 2015-10-22 | Novintethical Pharma Sa | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
| US20160317388A1 (en) * | 2014-05-01 | 2016-11-03 | Sun Pharmaceutical Industries Limited | Dual-chamber pack for extended release suspension compositions |
| US20180093803A1 (en) * | 2016-10-05 | 2018-04-05 | Mead Johnson Nutrition Company | Container closure with compartment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1002332B (el) * | 1992-05-21 | 1996-05-16 | Mcneil-Ppc Inc. | Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. |
| EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
| US6231866B1 (en) * | 1998-04-30 | 2001-05-15 | Douglas G. Mann | Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same |
| ITMI20041577A1 (it) | 2004-07-30 | 2004-10-30 | Inge Spa | Dispositivo di chiusura con camera per un contenitore di sostanze da mantenersi separate fino all'erogazione |
| US9314494B2 (en) * | 2012-05-25 | 2016-04-19 | The United States Of America, As Represented By The Secretary Of Agriculture | Cranberry xyloglucan oligosaccharide composition |
| ITTO20120506A1 (it) | 2012-06-12 | 2013-12-13 | Inge Spa | Cappuccio per un flacone atto alla conservazione di sostanze da mantenersi separate fino alla loro applicazione. |
| ITTO20121006A1 (it) | 2012-11-20 | 2014-05-21 | Inge Spa | Dispositivo per la conservazione ermetica di una sostanza da miscelare ad un'altra contenuta in un contenitore. |
| US20140255365A1 (en) | 2013-03-11 | 2014-09-11 | Mead Johnson Nutrition Company | Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof |
| US20150094266A1 (en) * | 2013-06-11 | 2015-04-02 | Novintethical Pharma, SA | Xyloglucan and protein compositions for the treatment of intestinal disorders |
-
2018
- 2018-07-09 GR GR20180100307A patent/GR1009632B/el active IP Right Grant
-
2019
- 2019-07-05 DK DK19749778.7T patent/DK3820466T3/da active
- 2019-07-05 EP EP19749778.7A patent/EP3820466B1/en active Active
- 2019-07-05 ES ES19749778T patent/ES2928471T3/es active Active
- 2019-07-05 WO PCT/GR2019/000049 patent/WO2020012203A1/en not_active Ceased
- 2019-07-05 PT PT197497787T patent/PT3820466T/pt unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0990438A1 (en) * | 1998-09-21 | 2000-04-05 | McNEIL-PPC, INC. | Heat stable antacid and antigas suspensions |
| US20060269535A1 (en) * | 2005-05-31 | 2006-11-30 | Naidu A S | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy |
| WO2008018111A2 (en) * | 2006-08-09 | 2008-02-14 | Opocrin S.P.A. | Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections |
| WO2015158771A1 (en) * | 2014-04-15 | 2015-10-22 | Novintethical Pharma Sa | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
| US20160317388A1 (en) * | 2014-05-01 | 2016-11-03 | Sun Pharmaceutical Industries Limited | Dual-chamber pack for extended release suspension compositions |
| US20180093803A1 (en) * | 2016-10-05 | 2018-04-05 | Mead Johnson Nutrition Company | Container closure with compartment |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020012203A1 (en) | 2020-01-16 |
| ES2928471T3 (es) | 2022-11-18 |
| PT3820466T (pt) | 2022-10-21 |
| EP3820466B1 (en) | 2022-09-07 |
| EP3820466A1 (en) | 2021-05-19 |
| DK3820466T3 (da) | 2022-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| MX2015015356A (es) | Formulacion estabilizada de pemetrexed. | |
| CR20130244S (es) | Tapa para contenedor | |
| EA201390409A1 (ru) | Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием | |
| HRP20151337T1 (hr) | Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil- ili n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin | |
| UA105766C2 (uk) | Фармацевтична композиція, яка містить сіль стронцію, вітамін d і циклодекстрин | |
| MX2009009997A (es) | Preparacion de la capsula de tamibarotene. | |
| IN2014DN06737A (el) | ||
| EA201791147A1 (ru) | Фармацевтическая композиция, ее получение и применения | |
| EA201300539A1 (ru) | Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая | |
| CL2015002721A1 (es) | Formulaciones oftálmicas | |
| RU2013146037A (ru) | Косметическая композиция в виде эмульсии вода-в-масле | |
| RU2016131454A (ru) | Применения витамина d и его композиций для антибиоза | |
| WO2011145851A3 (ko) | 사이프러스 에센셜 복합 오일을 유효 성분으로 함유하는 기억력 증진 및 인지 기능 장애 개선을 위한 화장료 조성물 | |
| MX2014009660A (es) | Formulacion de anticuerpo anti-selectina p. | |
| EA202092418A1 (ru) | Композиция кремниевой кислоты и ее применение | |
| RU2013104950A (ru) | Натуральный лекарственный состав | |
| EA201200754A1 (ru) | Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение | |
| WO2013173803A3 (en) | Formulations of amoxicillin and clavulanate potassium and methods for using same | |
| WO2005044228A3 (en) | Compositions comprising cyclohexylamines and aminoadamantanes | |
| MX2020000009A (es) | Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos. | |
| WO2008018111A3 (en) | Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections | |
| MX2014008375A (es) | Formulaciones pedriaticas de supspension oral de amoxicilina y clauvulanato de potasio y metodo para su uso. | |
| ZA202200335B (en) | Pharmaceutical composition of temozolomide. | |
| MX2018010858A (es) | Particulas de liberacion de farmacos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PG | Patent granted |
Effective date: 20191128 |